In the News
The Burrill Report interviews Greg Scott on WuXi/CRL breakup and China's hot IPOs
 
Greg Scott joined Foley's Eye on China webinar on life science innovation
>>Foley webinar...
Site Search

>> Advanced Search

Free Newsletter

  Email address:
   

Anhui Anke Biotech Nearly Triples in ChiNext’s First Day

publication date: Oct 30, 2009
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

The Shenzhen Growth Market, now called ChiNext, opened for its first day of business today, and Anhui Anke Biotechnology (Group) Co Ltd was the star performer, nearly tripling in value in its first day of open market trading. 28 medium and small-sized China companies listed on the exchange and each of the 28 did well in the first day. In fact, at one point, each was up at least 45%. However, Anhui Anke was the standout performer. More details...

Stock Symbol: (300009)




Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...


Login

 

 
   
ChinaBio® Events
BioBay Investor Forum 2010
Suzhou, China
November 3 - 4, 2010
China Forum 2010
Munich, Germany
November 14, 2010

 
ChinaBio® Investor Forum 2010 - Guangzhou
Guangzhou, China
December 21, 2010
Partner Events
BioPharm America™ 2010
Boston, MA, USA
September 15–17, 2010

CALAsia 2010
San Diego, USA
October 4-5, 2010

CHINA PRETRIALS 2010: Global Preclinical Development Summit
Beijing, China
October 17-19, 2010

CHINA TRIALS 2010
Beijing, China
November 7-9, 2010

12th Shanghai International Forum on Biotechnology & Pharmaceutical Industry (BIO-FORUM)
Beijing, China
November 9-11, 2010
Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners